Lakefront Biotherapeutics Total Assets

Lakefront Biotherapeutics (GLPGF) currently reports a total assets of $3.4B as of March 2026. That compares with $4B in the prior-year period — down 16.1% year over year. Use the charts on this page to explore Lakefront Biotherapeutics's total assets history and peer comparisons.

Lakefront Biotherapeutics's total assets decreased from $4B to $3.4B — a 16.1% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lakefront Biotherapeutics reported $3.4B in total assets as of March 2026. That compares with $4B in the prior-year period — down 16.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $3.4B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lakefront Biotherapeutics, and consider following GLPGF for alerts when major investors trade the stock.

Lakefront Biotherapeutics is classified in the Healthcare sector. On total assets, it currently shows $3.4B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GLPGF with unrelated industries.